Fernandez A. Henry's Insider Trades & SAST Disclosures
Fernandez A. Henry's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 7,614 Class A Ordinary Shares done . Disclosure was reported to the exchange on May 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Fernandez A. Henry.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 7,614 | 64,260 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 32.87 per share. | 31 Mar 2025 | 1,141 | 56,646 | - | 32.9 | 37,500 | Class A Ordinary Shares |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 574.98 per share. | 24 Feb 2025 | 4,700 | 1,269,851 (1%) | 0% | 575.0 | 2,702,406 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 569.86 per share. | 24 Feb 2025 | 500 | 1,265,151 (1%) | 0% | 569.9 | 284,930 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 575.66 per share. | 24 Feb 2025 | 100 | 1,269,951 (1%) | 0% | 575.7 | 57,566 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 58,370 | 1,296,930 (1%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 587.48 per share. | 06 Feb 2025 | 32,279 | 1,264,651 (1%) | 0% | 587.5 | 18,963,267 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 44,920 | 44,920 | - | - | Premium option to purchase common stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 40,780 | 40,780 | - | - | Premium option to purchase common stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,846 | 36,846 | - | - | Premium option to purchase common stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 29,564 | 29,564 | - | - | Option to purchase common stock | |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 24.94 per share. | 31 Dec 2024 | 1,503 | 55,505 | - | 24.9 | 37,487 | Class A Ordinary Shares |
| MSCI Inc | Fernandez A. Henry | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 613.38 per share. | 05 Dec 2024 | 1,807 | 329,886 (0%) | 0% | 613.4 | 1,108,378 | Common Stock |
| MSCI Inc | A. Henry Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 610.00 per share. | 05 Dec 2024 | 600 | 328,079 (0%) | 0% | 610 | 366,000 | Common Stock |
| MSCI Inc | A. Henry Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 614.08 per share. | 05 Dec 2024 | 493 | 330,379 (0%) | 0% | 614.1 | 302,741 | Common Stock |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 27.92 per share. | 30 Sep 2024 | 1,342 | 54,002 | - | 27.9 | 37,475 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 26.80 per share. | 28 Jun 2024 | 1,399 | 52,660 | - | 26.8 | 37,493 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,293 | 51,261 | - | 0 | Class A Ordinary Shares | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 15,400 (0%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 15,400 (0%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 1,760,267 (2%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 15,400 (0%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 1,745,267 (2%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 1,752,767 (2%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 468.52 per share. | 25 Apr 2024 | 4,294 | 325,835 (0%) | 0% | 468.5 | 2,011,825 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 469.66 per share. | 25 Apr 2024 | 1,644 | 327,479 (0%) | 0% | 469.7 | 772,121 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 464.55 per share. | 25 Apr 2024 | 1,600 | 319,793 (0%) | 0% | 464.6 | 743,280 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 461.92 per share. | 25 Apr 2024 | 1,445 | 317,330 (0%) | 0% | 461.9 | 667,474 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 467.24 per share. | 25 Apr 2024 | 988 | 321,541 (0%) | 0% | 467.2 | 461,633 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 460.69 per share. | 25 Apr 2024 | 906 | 315,885 (0%) | 0% | 460.7 | 417,385 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 462.96 per share. | 25 Apr 2024 | 863 | 318,193 (0%) | 0% | 463.0 | 399,534 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 465.74 per share. | 25 Apr 2024 | 760 | 320,553 (0%) | 0% | 465.7 | 353,962 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 459.48 per share. | 25 Apr 2024 | 500 | 314,979 (0%) | 0% | 459.5 | 229,740 | Common Stock |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 30.23 per share. | 28 Mar 2024 | 1,240 | 41,968 | - | 30.2 | 37,483 | Class A Ordinary Shares |
| MSCI Inc | A. Henry Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 84,022 | 1,559,427 (1%) | 0% | 0 | Common Stock | |
| MSCI Inc | A. Henry Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 583.39 per share. | 05 Feb 2024 | 46,465 | 1,512,962 (1%) | 0% | 583.4 | 27,107,216 | Common Stock |
| MSCI Inc | Henry Fernandez A. | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 7,298 | 1,520,260 (1%) | 0% | 0 | Common Stock | |
| MSCI Inc | A. Henry Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 583.39 per share. | 05 Feb 2024 | 4,036 | 1,516,224 (1%) | 0% | 583.4 | 2,354,562 | Common Stock |
| Royalty Pharma plc - Ordin... | A. Fernandez Henry | Director | Grant, award, or other acquisition of securities at price $ 27.71 per share. | 29 Dec 2023 | 1,353 | 40,728 | - | 27.7 | 37,493 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 31.03 per share. | 30 Jun 2023 | 1,208 | 37,991 | - | 31.0 | 37,481 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,747 | 36,783 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 35.73 per share. | 31 Mar 2023 | 1,049 | 29,036 | - | 35.7 | 37,478 | Class A Ordinary Shares |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,472 | 1,239,585 (1%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 556.90 per share. | 08 Feb 2023 | 15,746 | 1,223,839 (1%) | 0% | 556.9 | 8,768,947 | Common Stock |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 39.76 per share. | 30 Dec 2022 | 943 | 27,987 | - | 39.8 | 37,495 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 41.06 per share. | 30 Sep 2022 | 913 | 27,044 | - | 41.1 | 37,490 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 41.52 per share. | 30 Jun 2022 | 903 | 26,131 | - | 41.5 | 37,493 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,328 | 25,228 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 38.87 per share. | 31 Mar 2022 | 964 | 18,900 | - | 38.9 | 37,471 | Class A Ordinary Shares |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 80,187 | 1,253,573 (1%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.45 per share. | 07 Feb 2022 | 42,460 | 1,211,113 (1%) | 0% | 550.5 | 23,372,107 | Common Stock |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 7,170 | 7,900 (0%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 7,170 | 1,676,495 (1%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 4,275 | 1,683,665 (1%) | 0% | 0 | Common Stock | |
| MSCI Inc | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 4,275 | 7,900 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 37.80 per share. | 30 Sep 2021 | 992 | 16,978 | - | 37.8 | 37,499 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 43.04 per share. | 30 Jun 2021 | 871 | 15,986 | - | 43.0 | 37,489 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 5,726 | 15,115 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 45.90 per share. | 31 Mar 2021 | 816 | 9,529 | - | 45.9 | 37,458 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Purchase of securities on an exchange or from another person at price $ 46.83 per share. | 25 Feb 2021 | 25,700 | 25,700 | - | 46.8 | 1,203,480 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 45.69 per share. | 31 Dec 2020 | 820 | 8,713 | - | 45.7 | 37,464 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 41.17 per share. | 30 Sep 2020 | 613 | 7,893 | - | 41.2 | 25,240 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 7,280 | 7,280 | - | 0 | Class A Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges